NEXHA owner Contact Information online
from VETOQUINOL U.S.A. INC.
NEXHA
US serial number:85084419
Application filling date:Jul. 14, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Aug. 05, 2014
Publication date:Apr. 05, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign priority claimed:Yes
Foreign foreign application number:1487101
Foreign foreign application filling date:Jun. 30, 2010
Foreign foreign application registration country:CANADA
Goods and services:For: Veterinary preparation for the treatment of joint dysfunction associated with equine osteoarthritis
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(a)
First Use: Jan. 31, 2013
Use in Co
Services:Veterinary preparation for the treatment of joint dysfunction associated with equine osteoarthritis
Current owner owner name:VETOQUINOL U.S.A. INC.
Current owner owner address:4250 N. SYLVANIA AVE,
FORT WORTH,
TEXAS
UNITED STATES
76137
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Lori K. Hall
Attorney email:lori.hall@gowlings.com
Attorney email authorized:Yes
Correspondent name address:Lori K. Hall
Gowling Lafleur Henderson LLP
One Main Street West
Hamilton, Ontario
CANADA
L8P4Z5
Correspondent phone:(905) 540-3275
Correspondent email:lori.hall@gowlings.com
penny.fede@gowlings.com
Correspondent email authorized:Yes
Domestic representative name:Deborah Peckham
Domestic representative phone NEXHA:(905) 540-3275
Latest trademarks
Popular owners
Glaxo Group Limited (174) Novartis AG (130) JOHNSON & JOHNSON (126) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (34) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Apr. 05, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
